// App-Quantinova.ai

3943 : Lenalidomide Suppresses 5?-Cap-Independent C-MYC Translation in Multiple Myeloma Cells

Researchers

Presenter

  • Jordan Johnson

Principal Investigators

  • Paola Neri

  • K Gratton

  • Li Ren

  • Douglas A. Stewart

  • Peter Duggan

  • Nizar J. Bahlis

Medical Centers

  • Department of Surgery, University of Calgary, Calgary, AB, Canada

  • University of Calgary, Southern Alberta Cancer Research Institute, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Annexin V

Drug/Treatment

  • Lenalidomide

  • Rapacan

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim